Association of low pregnancy-associated plasma protein A with the timing of delivery in babies with intrauterine growth restriction, babies showing suboptimal growth on serial scans, and well-grown babies
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251972Keywords:
Papp-A, Suboptimal growth, Stillbirth, SCBU admissions, APGAR <7, IUGRAbstract
Background: The ideal timing for delivering babies with pre-eclampsia or small for gestational age is clear. There is agreement on delivering babies with pre-eclampsia and small for gestational age, but not for normally growing babies with low pregnancy-associated plasma protein A (PAPP-A). The study aimed to investigate the association of low PAPP-A with adverse pregnancy outcomes and ideal delivery timing in a well-grown baby with low PAPP-A as a risk factor.
Methods: A retrospective study analyzed 3240 singleton pregnancies with first-trimester Down syndrome screening at local hospitals from January 2022 to April 2023. Among these, 130 singleton pregnancies had PAPP-A levels at the 5th centile, along with risk estimations and documentation.
Results: In NCIC trust births, 3280 women were assessed for low PAPP-A. Of these, 130 had low PAPP-A levels. It revealed that 46.9% used Aspirin, with a high down screen risk found in 11.5%. In this study, 13.1% experienced pregnancy induced hypertension (PIH). 2 resulted in intrauterine fetal death (1.5%). 9 women (6.9%) experienced pre-term births. The study identified 8 newborns (6.25%) with birth weights below the 10th centile after >39+6 weeks, and 6 (4.6%) <3rd centile after 37+6 weeks.
Conclusions: The study linked low PAPP-A to poor APGAR scores, stillbirth, growth issues, and special care unit admissions. Babies with low PAPP-A showed higher morbidity and mortality after 41 weeks. The findings indicate that delivery should occur between 40+0 and 40+6 weeks. Further research is needed to create an antenatal protocol for optimal delivery timing for babies with low PAPP-A.
Metrics
References
Antsaklis P, Fasoulakis Z, Theodora M, Diakosavvas M, Kontomanolis EN. Association of low maternal pregnancy-associated plasma protein A with adverse perinatal outcome. Cureus. 2019;11(6):e4912. DOI: https://doi.org/10.7759/cureus.4912
Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. Bratisl Lek Listy. 2002;103:194-205.
Odibo AO, Patel KR, Spitalnik A, Odibo L, Huettner. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol. 2014;34:186-91. DOI: https://doi.org/10.1038/jp.2013.176
Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy‐associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia and stillbirth. J Clin Endocrinol Metab. 2002;87:1762-7.
Scott F, Coates A, McLennan A. Pregnancy outcome in the setting of extremely low first trimester PAPP‐A levels. Aust N Z J Obstet Gynaecol. 2009;49:258-62. DOI: https://doi.org/10.1111/j.1479-828X.2009.01001.x
Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762-7. DOI: https://doi.org/10.1210/jcem.87.4.8430
Marttala J, Peuhkurinen S, Laitinen P, Gissler M, Nieminen P, Ryynanen M. Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths. Acta Obstet Gynecol Scand. 2010;89(9):1226-8. DOI: https://doi.org/10.3109/00016349.2010.493195
NICE guideline. Inducing labour. 2021. Available at: https://www.nice.org.uk/guidance/ng207. Accessed on 12 May 2025.
Grobman WA, Caughey AB. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies. Am J Obstet Gynecol. 2019;221(4):304-10. DOI: https://doi.org/10.1016/j.ajog.2019.02.046
Kazemi Aski S, Sharami SH, Tavangar A, Kazemnezhad E, Dalil Heirati SF, Etezadi A. Comparison of Pregnancy-Associated Plasma Protein-A Levels in Women with and Without Intrauterine Growth Restriction. J Obstet Gynecol Cancer Res. 2024;9(1):14-21. DOI: https://doi.org/10.30699/jogcr.9.1.14
Jindal A, Polipalli SK, Kapoor S, Mishra R. Adverse pregnancy outcome in low PAPP-A levels: First trimester screeninghospital based study. Int J Clin Biochem Res. 2023;10(3):200-3. DOI: https://doi.org/10.18231/j.ijcbr.2023.035
Dias da Silva C, Sarmento Gonçalves I, Ramalho C. Association of low pregnancy associated plasma protein-A with increased umbilical artery pulsatility index in cases of fetal weight between the 3rd and 10th percentiles: a retrospective cohort study. J Perinat Med. 2023;52(1):90-5. DOI: https://doi.org/10.1515/jpm-2023-0156
Middleton P, Shepherd E, Morris J, Crowther CA, Gomersall JC. Induction of labour at or beyond 37 weeks' gestation. Cochrane Database Syst Rev. 2020;7(7):CD004945. DOI: https://doi.org/10.1002/14651858.CD004945.pub5
Downloads
Published
How to Cite
Issue
Section
